Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Advances in Experimental Medicine and Biology|October 28, 2022
Magnetic Resonance Imaging BasicsAtul Singh Minhas, Ruth Oliver
Clinical Neuropharmacology|November 4, 2008
Pharmacokinetic and pharmacodynamic comparison of ropinirole 24-hour prolonged release and ropinirole immediate release in patients with Parkinson's diseaseDebra Tompson, Ruth Oliver-Willwong
IEEE Reviews in Biomedical Engineering|October 16, 2019
Automated Brain Tumor Segmentation Using Multimodal Brain Scans: A Survey Based on Models Submitted to the BraTS 2012-2018 ChallengesMina Ghaffari, Arcot Sowmya, Ruth Oliver
CPT: Pharmacometrics & Systems Pharmacology|November 4, 2021
Pharmacokinetic-pharmacodynamic modelling of the anti-FcRn monoclonal antibody rozanolixizumab: Translation from preclinical stages to the clinicRocio Lledo-Garcia, Kate Dixon, Anthony Shock, et al.
Journal of Clinical Pharmacology|December 1, 2022
Population Pharmacokinetics and Exposure-Response for Dapirolizumab Pegol From a Phase 2b Trial in Patients With Systemic Lupus ErythematosusChayan Acharya, Mats O Magnusson, Pavan Vajjah, et al.
Clinical Pharmacology in Drug Development|April 30, 2016
Safety and pharmacokinetics of olokizumab, an anti-IL-6 monoclonal antibody, administered to healthy male volunteers: A randomized phase I studyKosmas Kretsos, Georg Golor, Astrid Jullion, et al.
British Journal of Clinical Pharmacology|July 30, 2008
Lamotrigine does not prolong QTc in a thorough QT/QTc study in healthy subjectsRuth Dixon, Sarah Job, Ruth Oliver, et al.
Journal of Clinical Pharmacology|March 5, 2015
Population pharmacokinetic analysis of certolizumab pegol in patients with Crohn's diseaseJanet R Wade, Gerry Parker, Gordana Kosutic, et al.
Magnetic Resonance Imaging|October 29, 2021
Automated post-operative brain tumour segmentation: A deep learning model based on transfer learning from pre-operative imagesMina Ghaffari, Gihan Samarasinghe, Michael Jameson, et al.
Epilepsia|September 11, 2007
Steady-state pharmacokinetics of lamotrigine when converting from a twice-daily immediate-release to a once-daily extended-release formulation in subjects with epilepsy (The COMPASS Study)Debra J Tompson, Imran Ali, Ruth Oliver-Willwong, et al.
Pageof 2